Logo image of LBGJ

LI BANG INTERNATIONAL CORP I (LBGJ) Stock Fundamental Analysis

USA - NASDAQ:LBGJ - KYG5480M1024 - Common Stock

0.64 USD
-0.01 (-1.99%)
Last: 10/24/2025, 8:00:02 PM
0.66 USD
+0.02 (+3.13%)
After Hours: 10/24/2025, 8:00:02 PM
Fundamental Rating

1

Overall LBGJ gets a fundamental rating of 1 out of 10. We evaluated LBGJ against 130 industry peers in the Machinery industry. Both the profitability and financial health of LBGJ have multiple concerns. LBGJ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LBGJ has reported negative net income.
LBGJ had a negative operating cash flow in the past year.
LBGJ Yearly Net Income VS EBIT VS OCF VS FCFLBGJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M 2M 3M

1.2 Ratios

LBGJ has a Return On Assets of -8.67%. This is in the lower half of the industry: LBGJ underperforms 78.46% of its industry peers.
LBGJ has a worse Return On Equity (-32.19%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA -8.67%
ROE -32.19%
ROIC N/A
ROA(3y)0.38%
ROA(5y)N/A
ROE(3y)-1.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LBGJ Yearly ROA, ROE, ROICLBGJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

The Gross Margin of LBGJ (22.88%) is worse than 68.46% of its industry peers.
LBGJ's Gross Margin has declined in the last couple of years.
LBGJ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.42%
GM growth 5YN/A
LBGJ Yearly Profit, Operating, Gross MarginsLBGJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

LBGJ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LBGJ has less shares outstanding
Compared to 1 year ago, LBGJ has a worse debt to assets ratio.
LBGJ Yearly Shares OutstandingLBGJ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
LBGJ Yearly Total Debt VS Total AssetsLBGJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

LBGJ has an Altman-Z score of 1.00. This is a bad value and indicates that LBGJ is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LBGJ (1.00) is worse than 77.69% of its industry peers.
LBGJ has a Debt/Equity ratio of 1.36. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of LBGJ (1.36) is worse than 83.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Altman-Z 1
ROIC/WACCN/A
WACC7.6%
LBGJ Yearly LT Debt VS Equity VS FCFLBGJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M

2.3 Liquidity

LBGJ has a Current Ratio of 1.85. This is a normal value and indicates that LBGJ is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of LBGJ (1.85) is comparable to the rest of the industry.
A Quick Ratio of 1.70 indicates that LBGJ should not have too much problems paying its short term obligations.
LBGJ has a Quick ratio of 1.70. This is in the better half of the industry: LBGJ outperforms 73.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.7
LBGJ Yearly Current Assets VS Current LiabilitesLBGJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for LBGJ have decreased strongly by -216.89% in the last year.
The Revenue for LBGJ has decreased by -12.54% in the past year. This is quite bad
The Revenue for LBGJ have been decreasing by -12.12% on average. This is quite bad
EPS 1Y (TTM)-216.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.14%
Revenue 1Y (TTM)-12.54%
Revenue growth 3Y-12.12%
Revenue growth 5YN/A
Sales Q2Q%26.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LBGJ Yearly Revenue VS EstimatesLBGJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LBGJ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LBGJ Price Earnings VS Forward Price EarningsLBGJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LBGJ Per share dataLBGJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LBGJ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LI BANG INTERNATIONAL CORP I

NASDAQ:LBGJ (10/24/2025, 8:00:02 PM)

After market: 0.66 +0.02 (+3.13%)

0.64

-0.01 (-1.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.00M
Revenue(TTM)15.51M
Net Income(TTM)-2496100
AnalystsN/A
Price TargetN/A
Short Float %0.05%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.77
P/FCF N/A
P/OCF N/A
P/B 1.55
P/tB 1.66
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.83
BVpS0.41
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.67%
ROE -32.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.88%
FCFM N/A
ROA(3y)0.38%
ROA(5y)N/A
ROE(3y)-1.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.42%
GM growth 5YN/A
F-Score2
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.5%
Cap/Sales 0.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.7
Altman-Z 1
F-Score2
WACC7.6%
ROIC/WACCN/A
Cap/Depr(3y)24.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.95%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-216.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.54%
Revenue growth 3Y-12.12%
Revenue growth 5YN/A
Sales Q2Q%26.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-775.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.91%
OCF growth 3YN/A
OCF growth 5YN/A

LI BANG INTERNATIONAL CORP I / LBGJ FAQ

Can you provide the ChartMill fundamental rating for LI BANG INTERNATIONAL CORP I?

ChartMill assigns a fundamental rating of 1 / 10 to LBGJ.


Can you provide the valuation status for LI BANG INTERNATIONAL CORP I?

ChartMill assigns a valuation rating of 0 / 10 to LI BANG INTERNATIONAL CORP I (LBGJ). This can be considered as Overvalued.


What is the profitability of LBGJ stock?

LI BANG INTERNATIONAL CORP I (LBGJ) has a profitability rating of 0 / 10.


How financially healthy is LI BANG INTERNATIONAL CORP I?

The financial health rating of LI BANG INTERNATIONAL CORP I (LBGJ) is 2 / 10.